Literature DB >> 3515180

Characterization of a hemoglobin-degrading, low molecular weight protease from Plasmodium falciparum.

D L Vander Jagt, L A Hunsaker, N M Campos.   

Abstract

A protease from Plasmodium falciparum was purified 150 fold by high performance liquid chromatography on a TSK-G-3000 SW exclusion column. The enzyme is not retained during pressure filtration with an Amicon PM10 membrane but is retained by a YM5 membrane. The molecular weight of the protease is less than 10,000, based upon mobility on a calibrated TSK column. The enzyme catalyzes the hydrolysis both of acid denatured hemoglobin and of albumin. The hydrolysis is optimal at pH4.5, but considerable activity is seen at pH 6.0. Pepstatin strongly inhibits the protease (I50 = 70 nM) while bestatin, antipain and phosphoramidon produce moderate inhibition (I50 = 30, 30 and 3 microM, respectively). The protease is inhibited by ferriprotoporphyrin IX (I50 ca. 5 microM). This inhibition is insensitive to pH between pH 4.5 and 6. Although chloroquine does not strongly inhibit the protease, chloroquine-ferriprotoporphyrin IX complex produces inhibition similar to that of ferriprotoporphyrin IX. It is suggested that the antimalarial effect of chloroquine is due to the formation of ferriprotoporphyrin IX-chloroquine complex which prevents the sequestration of ferriprotoporphyrin IX into malarial pigment, thereby providing both ferriprotoporphyrin IX and its chloroquine complex as inhibitors of one of the proteases required for the degradation of hemoglobin.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3515180     DOI: 10.1016/0166-6851(86)90095-2

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN: 0166-6851            Impact factor:   1.759


  15 in total

1.  Transcriptomic and proteomic profile of Aspergillus fumigatus on exposure to artemisinin.

Authors:  Poonam Gautam; Santosh Kumar Upadhyay; Wazid Hassan; Taruna Madan; Ravi Sirdeshmukh; Curam Sreenivasacharlu Sundaram; Wasudev Namdeo Gade; Seemi Farhat Basir; Yogendra Singh; Puranam Usha Sarma
Journal:  Mycopathologia       Date:  2011-07-14       Impact factor: 2.574

2.  The native form of the Plasmodium falciparum Pf68 neutral proteinase is a 105,000-Da polypeptide.

Authors:  P Lawton; C Barrault; P Grellier; J Schrével; H G Heidrich
Journal:  Parasitol Res       Date:  1991       Impact factor: 2.289

Review 3.  Antimalarial agents: mechanisms of action.

Authors:  P H Schlesinger; D J Krogstad; B L Herwaldt
Journal:  Antimicrob Agents Chemother       Date:  1988-06       Impact factor: 5.191

Review 4.  Malaria parasite plasmepsins: More than just plain old degradative pepsins.

Authors:  Armiyaw S Nasamu; Alexander J Polino; Eva S Istvan; Daniel E Goldberg
Journal:  J Biol Chem       Date:  2020-05-04       Impact factor: 5.157

5.  Order and specificity of the Plasmodium falciparum hemoglobin degradation pathway.

Authors:  I Y Gluzman; S E Francis; A Oksman; C E Smith; K L Duffin; D E Goldberg
Journal:  J Clin Invest       Date:  1994-04       Impact factor: 14.808

6.  Esterase mutation is a mechanism of resistance to antimalarial compounds.

Authors:  Eva S Istvan; Jeremy P Mallari; Victoria C Corey; Neekesh V Dharia; Garland R Marshall; Elizabeth A Winzeler; Daniel E Goldberg
Journal:  Nat Commun       Date:  2017-01-20       Impact factor: 14.919

7.  A malarial cysteine proteinase is necessary for hemoglobin degradation by Plasmodium falciparum.

Authors:  P J Rosenthal; J H McKerrow; M Aikawa; H Nagasawa; J H Leech
Journal:  J Clin Invest       Date:  1988-11       Impact factor: 14.808

8.  In vitro antimalarial activity of a new organometallic analog, ferrocene-chloroquine.

Authors:  O Domarle; G Blampain; H Agnaniet; T Nzadiyabi; J Lebibi; J Brocard; L Maciejewski; C Biot; A J Georges; P Millet
Journal:  Antimicrob Agents Chemother       Date:  1998-03       Impact factor: 5.191

Review 9.  [Malaria--biological aspects of an infectious disease of importance to humans].

Authors:  J P Hildebrandt
Journal:  Naturwissenschaften       Date:  1996-08

10.  Inhibition of a Plasmodium vinckei cysteine proteinase cures murine malaria.

Authors:  P J Rosenthal; G K Lee; R E Smith
Journal:  J Clin Invest       Date:  1993-03       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.